Drug Type Chemical drugs |
Synonyms MRANK 108, MRANK108 |
Target |
Action inhibitors |
Mechanism CDK7 inhibitors(Cyclin-dependent kinase 7 inhibitors) |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhaseDiscontinuedPreclinical |
First Approval Date- |
Regulation- |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Pancreatic Cancer | Preclinical | China | 11 Jun 2024 |





